Medspa Staffing & Salary Guide: RN Injector, NP, Aesthetician

RN injectors (registered nurses with injection certification or experience) typically command $55,000–$85,000 annually in mid-market metros, with top-tier markets (NYC, LA, Miami, San Francisco) pushing $90,000–$120,000+. Compensation structure matters: base salary alone underperforms; most profitable practices layer base ($45,000–$65,000) with production bonus tied to toxin/filler revenue (typically 5–15% of gross revenue per injector, or per-syringe/per-unit incentives). An RN injector generating $400,000 in annual revenue at 10% bonus earns $40,000 on top of base—critical for retention. Experience and credentials (ASPS membership, advanced training in facial anatomy) command 15–25% premiums. Turnover in this role runs 25–40% annually in high-cost markets; practices that offer clear advancement (lead injector, trainer, medical director track) and transparent bonus formulas retain staff 40–50% longer. State scope-of-practice rules vary sharply: some states allow RNs to inject independently under standing orders; others require physician supervision or NP/PA oversight. Verify your state board's delegation rules before hiring; misclassification exposes you to liability and audit.

NPs and PAs occupy a hybrid role: clinical authority, regulatory compliance, and revenue generation. Compensation ranges $90,000–$150,000 base in mid-market metros, $130,000–$200,000+ in major metros or high-acuity practices. Unlike RN injectors, NPs/PAs often command lower production bonuses (3–8%) because their primary value is regulatory: they sign off on protocols, supervise delegated staff, manage complications, and shield the practice from scope-of-practice violations. Many practices structure NP/PA roles as salaried with modest bonus rather than heavy production incentive, because their time is split between patient care, chart review, and compliance. However, NPs/PAs who actively inject and treat patients can generate $300,000–$600,000 in annual revenue; practices that incentivize this (bonus on their own injections plus supervisory fee per RN they oversee) see better utilization. State regulations again matter: some states allow NPs to own/operate a medspa independently; others require physician oversight. PA scope is narrower and always requires physician supervision. Verify your state's NP independent-practice rules and physician-supervision requirements before structuring compensation.

Aestheticians (facials, laser, microneedling, chemical peels) earn $30,000–$50,000 base in mid-market metros, $40,000–$70,000 in high-cost markets. Unlike injectors, aesthetician revenue per hour is lower and more commoditized; practices often pay base + small production bonus (2–5% of revenue) or commission-only hybrid. Turnover is severe (40–60% annually) because aestheticians are highly mobile—they can move to spas, salons, or independent practices with lower barriers. Retention levers: clear advancement to lead aesthetician or trainer roles, continuing education (laser certifications, advanced peels), and transparent scheduling (predictable hours, no last-minute cancellations). Front-desk and administrative staff earn $28,000–$45,000 depending on market and complexity (scheduling, insurance verification, patient follow-up). These roles are often overlooked in compensation planning but directly impact injector productivity: a disorganized front desk creates no-shows, missed upsells, and injector downtime. Practices that invest in front-desk training and modest raises (3–5% annually) see 20–30% fewer scheduling errors and higher patient lifetime value.

Compensation is not uniform. Tier-1 metros (NYC, Los Angeles, Miami, San Francisco, Boston) run 30–50% higher than national medians: RN injectors $100,000–$130,000, NPs $160,000–$220,000. Tier-2 metros (Chicago, Atlanta, Denver, Seattle, Austin) run 10–20% above national median. Secondary markets and suburbs track closer to national averages or 10–15% below. Rural and underserved areas see lower absolute wages but tighter talent pools—practices often compete on flexibility, equity, or non-wage benefits (loan forgiveness, CME allowance, flexible scheduling). Wage pressure is accelerating in Tier-1 markets due to (1) consolidation: DSOs and PE-backed roll-ups (Solta, Cutera, InMode partnerships) are acquiring independent practices and standardizing compensation upward to retain staff; (2) GLP-1 weight-loss drug adoption: Galderma reported 25% YoY aesthetics revenue growth in H1 2026, driven by post-weight-loss skin tightening demand, which increases patient volume and compresses available clinical labor; (3) competing modalities: RF microneedling, laser, and biostimulator demand pulls aestheticians and RNs into higher-skill roles, raising floor wages. If you're in a Tier-1 market and losing staff to DSOs or competing practices, expect to raise base 5–10% annually just to hold talent.

Production bonuses work only if they're transparent, achievable, and paid promptly. Per-syringe or per-unit models (e.g., $X per syringe of Juvéderm, $Y per unit of Botox) are simple but create perverse incentives: injectors may over-treat or recommend unnecessary volume. Revenue-share models (% of gross revenue per injector) align better with practice health but require accurate tracking and clear attribution. Tiered bonuses (e.g., 5% on first $300k revenue, 10% on $300k–$500k, 15% above $500k) reward high performers and scale with practice growth. Supervisory bonuses for NPs/PAs (flat fee per RN supervised, or % of supervised RN revenue) incentivize delegation and team building. Retention bonuses (lump sum at 1-year or 2-year mark, or vesting equity in DSO/group) reduce turnover. Best practice: communicate bonus structure quarterly, show each staff member their YTD revenue and bonus accrual, and adjust annually based on market and practice performance. Practices that hide bonus calculations or pay inconsistently see 30–40% higher turnover.

Salary alone does not retain clinical staff in tight markets. Continuing education: allocate $1,500–$3,000 per RN/NP annually for training, certifications, conferences. ASPS membership ($400–$600/year) and hands-on toxin/filler training (often $2,000–$5,000 per course) signal investment in skill and career. Flexible scheduling: RNs and aestheticians value predictable, flexible hours; practices that offer 4-day weeks, shift choice, or remote admin days see 15–25% lower turnover. Equity or profit-sharing: if you're building a multi-location group or planning exit, offering equity vesting (1–2% per year over 4–5 years) or profit-sharing (2–5% of net profit) creates ownership mentality and reduces poaching. Health benefits: comprehensive health insurance (employer covers 80%+ of premium), 401(k) match (3–4%), and paid time off (15–20 days) are table-stakes in Tier-1 markets and increasingly expected in Tier-2. Loan forgiveness or sign-on bonus: for NPs/PAs with student debt, $10,000–$25,000 sign-on or annual loan-repayment assistance ($200–$500/month) is tax-deductible and highly valued. Practices competing in tight labor markets should budget 25–35% of revenue for total compensation (salary + bonus + benefits + training); practices in looser markets can run 20–25%.